Biovance Capital Partners is a venture
capital firm based in Lisbon that manages Biovance Capital Fund I. This is a €51 million biotech-focused fund backed by the European Investment Fund and other public and private investors.
Biovance Capital works closely
with entrepreneurs to build leading companies with transformative treatments for patients in need. We
invest in seed and Series A rounds and typically bring additional investors to add value and mitigate
risk.